Planet Labs' Revenue Soars, But Convertible Notes Drive Wider Loss

TL;DR

**Planet Labs is growing revenue fast, but the massive jump in warrant liabilities and new debt means profitability is still a distant dream, making it a risky bet right now.**

AI Summary

Planet Labs PBC reported a significant increase in revenue for the three months ended October 31, 2025, reaching $81.254 million, up from $61.266 million in the same period of 2024, representing a 32.6% increase. For the nine months ended October 31, 2025, revenue grew to $220.905 million from $182.798 million in 2024, an increase of 20.8%. Despite this revenue growth, the company experienced a substantial net loss of $59.185 million for the three months ended October 31, 2025, compared to a net loss of $20.081 million in the prior year, primarily driven by a $43.473 million change in fair value of warrant liabilities. The nine-month net loss also widened to $94.405 million from $88.042 million. Cash and cash equivalents significantly increased to $443.349 million as of October 31, 2025, from $118.048 million at January 31, 2025, largely due to $448.759 million in proceeds from the issuance of convertible notes. Total liabilities surged to $756.502 million from $192.510 million, mainly due to the new convertible notes and an increase in public and private placement warrant liabilities to $56.820 million from $18.077 million.

Why It Matters

Planet Labs' substantial revenue growth of 32.6% year-over-year for the quarter indicates strong demand for its geospatial data, which is positive for investors and customers relying on its services. However, the significant increase in net loss, largely due to warrant liabilities and new convertible notes, raises concerns about profitability and dilution for existing shareholders. The influx of cash from convertible notes provides capital for strategic investments and operations, but also adds considerable debt to the balance sheet, impacting the company's financial flexibility and competitive position against other satellite imagery providers. Employees might see this as a mixed signal, with growth opportunities balanced against financial pressures.

Risk Assessment

Risk Level: high — The risk level is high due to a significant increase in net loss to $59.185 million for the quarter, primarily driven by a $43.473 million change in fair value of warrant liabilities. Additionally, total liabilities surged to $756.502 million from $192.510 million, largely due to $446.201 million in new convertible notes, which introduces substantial debt and potential future dilution.

Analyst Insight

Investors should closely monitor Planet Labs' ability to convert its strong revenue growth into profitability and manage its increased debt load. Consider the impact of potential warrant exercises and convertible note conversions on future share dilution before making any investment decisions.

Financial Highlights

debt To Equity

2.16

revenue

$81.254M

operating Margin

N/A

total Assets

$1,106.060M

total Debt

$446.201M

net Income

-$59.185M

eps

-$0.19

gross Margin

57.3%

cash Position

$443.349M

revenue Growth

+32.6%

Key Numbers

• $81.254M — Revenue (Increased 32.6% for the three months ended October 31, 2025, from $61.266M in 2024.)
• $59.185M — Net Loss (Widened significantly for the three months ended October 31, 2025, from $20.081M in 2024.)
• $43.473M — Change in fair value of warrant liabilities (Major contributor to the increased net loss for the three months ended October 31, 2025.)
• $446.201M — Convertible Notes (New liability as of October 31, 2025, significantly increasing total liabilities.)
• $443.349M — Cash and Cash Equivalents (Increased substantially from $118.048M at January 31, 2025, largely due to convertible notes.)
• $756.502M — Total Liabilities (Surged from $192.510M at January 31, 2025, primarily due to convertible notes.)
• $0.19 — Basic and Diluted Net Loss Per Share (Increased for the three months ended October 31, 2025, from $0.07 in 2024.)
• 309,248,247 — Weighted-Average Common Shares Outstanding (Increased from 293,338,324 in 2024, indicating potential dilution.)

Key Players & Entities

• Planet Labs PBC (company) — registrant
• dMY Technology Group, Inc. IV (company) — SPAC involved in merger
• U.S. Securities and Exchange Commission (regulator) — filing authority
• New York Stock Exchange (regulator) — exchange for Class A Common Stock and Warrants
• $81.254 million (dollar_amount) — revenue for three months ended October 31, 2025
• $61.266 million (dollar_amount) — revenue for three months ended October 31, 2024
• $59.185 million (dollar_amount) — net loss for three months ended October 31, 2025
• $43.473 million (dollar_amount) — change in fair value of warrant liabilities for three months ended October 31, 2025
• $446.201 million (dollar_amount) — convertible notes liability as of October 31, 2025
• $443.349 million (dollar_amount) — cash and cash equivalents as of October 31, 2025

FAQ

Risk Factors

• Fair Value of Warrant Liabilities [high — financial]: The company experienced a significant $43.473 million change in the fair value of warrant liabilities for the three months ended October 31, 2025. This volatility in warrant liability valuation directly impacted the net loss, contributing to its widening.
• Convertible Notes Issuance [high — financial]: Planet Labs issued $446.201 million in convertible notes by October 31, 2025. While this significantly boosted cash reserves to $443.349 million, it also led to a substantial increase in total liabilities to $756.502 million.
• Widening Net Loss [high — financial]: The net loss for the three months ended October 31, 2025, was $59.185 million, a significant increase from $20.081 million in the prior year. The nine-month net loss also grew to $94.405 million from $88.042 million.
• Cost of Revenue Increase [medium — operational]: Cost of revenue increased by 45.9% for the three months ended October 31, 2025, to $34.670 million from $23.749 million in the prior year. This outpaced revenue growth, potentially impacting gross margins.
• Increase in Public and Private Placement Warrant Liabilities [medium — financial]: These liabilities grew to $56.820 million as of October 31, 2025, from $18.077 million at January 31, 2025. This increase contributes to the overall rise in total liabilities.
• Deferred Revenue Growth [medium — financial]: Deferred revenue increased significantly to $145.857 million for current liabilities and $48.332 million for non-current liabilities as of October 31, 2025. This indicates future revenue streams but also represents an obligation.

Industry Context

Planet Labs operates in the rapidly evolving Earth observation and analytics market, facing competition from established players and emerging satellite constellations. The industry is characterized by increasing demand for geospatial data driven by climate change monitoring, defense, agriculture, and urban planning. Technological advancements in satellite imaging and data processing are key differentiators.

Regulatory Implications

As a publicly traded company, Planet Labs is subject to SEC regulations and reporting requirements. Changes in accounting standards, particularly those related to financial instruments and revenue recognition, could impact financial reporting. Compliance with data privacy and export control regulations is also crucial for its global operations.

What Investors Should Do

1. Monitor the impact of warrant liability fluctuations on net income.
2. Analyze the sustainability of revenue growth against cost of revenue increases.
3. Evaluate the long-term implications of the convertible note financing.
4. Assess the company's path to profitability.

Key Dates

• 2025-10-31: Quarterly Financial Reporting — Reported significant revenue growth of 32.6% but also a widened net loss, largely due to warrant liability fair value changes and increased operating costs.
• 2025-01-31: Previous Fiscal Year End — Provided a baseline for comparison, showing a lower cash position ($118.048M) and significantly lower total liabilities ($192.510M) before the convertible note issuance.

Glossary

Fair value of warrant liabilities

The estimated market value of outstanding warrants, which can fluctuate based on market conditions and the company's stock price. (A significant driver of the net loss in the current period, highlighting financial instrument volatility.)

Convertible notes

Debt instruments that can be converted into shares of the issuing company's stock under certain conditions. (A major source of funding for Planet Labs, significantly increasing cash but also total liabilities.)

Deferred revenue

Revenue that has been received by a company but not yet earned, typically because the goods or services have not yet been delivered or rendered. (Represents future revenue obligations and impacts cash flow management.)

Accumulated deficit

The total cumulative net losses of a company since its inception, less any cumulative net income. (Indicates the company has historically operated at a loss, with the deficit widening in the current period.)

Public and private placement warrant liabilities

Liabilities associated with warrants issued in public offerings or private placements, whose value can change. (Contributes to the overall liability structure and can impact net income through fair value adjustments.)

Year-Over-Year Comparison

Compared to the prior year, Planet Labs PBC has demonstrated robust revenue growth, with a 32.6% increase for the three months ended October 31, 2025. However, this growth has been overshadowed by a significantly widened net loss, primarily due to a substantial $43.473 million change in the fair value of warrant liabilities. Total liabilities have surged from $192.510 million to $756.502 million, largely driven by the issuance of $446.201 million in convertible notes, which also accounts for the dramatic increase in cash and cash equivalents from $118.048 million to $443.349 million.

Key Financial Figures

• $0.0001 — tered Class A Common Stock, par value $0.0001 per share PL New York Stock Exchang
• $11.50 — A Common Stock, at an exercise price of $11.50 per share PL WS New York Stock Exch

Filing Documents

• pl-20251031.htm (10-Q) — 4174KB
• pl-ex31_1.htm (EX-31.1) — 20KB
• pl-ex31_2.htm (EX-31.2) — 20KB
• pl-ex32_1.htm (EX-32.1) — 7KB
• pl-ex32_2.htm (EX-32.2) — 8KB
• 0001193125-25-314295.txt ( ) — 15064KB
• pl-20251031.xsd (EX-101.SCH) — 1440KB
• pl-20251031_htm.xml (XML) — 3340KB

- Financial Information

Part I. - Financial Information Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Operations 6 Condensed Consolidated Statements of Comprehensive Loss 7 Condensed Consolidated Statements of Stockholders' Equity 8 Condensed Consolidated Statements of Cash Flows 10 Notes to Condensed Consolidated Financial Statements 11 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 34 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 52 Item 4.

Controls and Procedures

Controls and Procedures 52

- Other Information

Part II - Other Information Item 1.

Legal Proceedings

Legal Proceedings 53 Item 1A.

Risk Factors

Risk Factors 53 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 98 Item 3. Defaults Upon Senior Securities 98 Item 4. Mine Safety Disclosures 98 Item 5. Other Information 98 Item 6. Exhibits 99

Signatures

Signatures 100 2 Table of Contents Unless the context otherwise requires, the "Company", "Planet", "we", "our", "us" and similar terms refer to Planet Labs PBC, a Delaware public benefit corporation (f/k/a dMY Technology Group, Inc. IV, a Delaware corporation), and its consolidated subsidiaries. Cautionary Note Regarding Forward Looking Information This Quarterly Report on Form 10-Q for the quarter ended October 31, 2025 (the "Form 10-Q" or "this report") includes statements that express Planet's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements." Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "seek," "may," "will," "could," "can," "should," "would," "believes," "predicts," "potential," "strategy," "opportunity," "aim," "continue," and similar expressions or the negative thereof, or discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals, are intended to identify such forward-looking statements. Forward-looking statements appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the markets in which Planet operates. Factors that may impact such forward-looking statements include: our future financial performance, including expectations regarding our revenue, cost of revenue, operating expenses, capital expenditures, cash flows and our ability to achieve profitability; our ability to attract and retain customers, including our ability to renew existing contracts and expand our relationships with existing customers; our expectations regarding the value of our offerings to our customers over time; our expecta

- Financial Information

Part I. - Financial Information

Financial Statements

Item 1. Financial Statements. Planet Labs PBC Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and par value amounts) October 31, 2025 January 31, 2025 Assets Current assets Cash and cash equivalents $ 443,349 $ 118,048 Restricted cash and cash equivalents, current 906 6,598 Short-term investments 233,975 104,027 Accounts receivable, net of allowance of $ 31 and $ 807 , respectively 46,332 55,833 Prepaid expenses and other current assets 29,581 17,719 Total current assets 754,143 302,225 Property and equipment, net 145,084 121,749 Capitalized internal-use software, net 21,062 18,974 Goodwill 138,954 136,349 Intangible assets, net 25,537 27,452 Restricted cash and cash equivalents, non-current 5,367 5,348 Operating lease right-of-use assets 13,950 19,752 Other non-current assets 1,963 1,947 Total assets $ 1,106,060 $ 633,796 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 3,448 $ 2,604 Accrued and other current liabilities 28,652 42,600 Deferred revenue 145,857 82,275 Liability from early exercise of stock options 2,689 5,378 Operating lease liabilities, current 7,943 9,221 Total current liabilities 188,589 142,078 Deferred revenue 48,332 11,182 Deferred hosting costs 5,273 5,368 Public and private placement warrant liabilities 56,820 18,077 Operating lease liabilities, non-current 7,209 12,392 Contingent consideration 3,601 2,883 Convertible notes 446,201 — Other non-current liabilities 477 530 Total liabilities 756,502 192,510 Commitments and contingencies (Note 9) Stockholders' equity Common stock, $ 0.0001 par value, 570,000,000 , 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at October 31, 2025 and January 31, 2025, 292,437,391 and 278,937,702 Class A shares issued and outstandi

View Full Filing

View this 10-Q filing on SEC EDGAR